Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05740254

Early vs. Late Time-Restricted Eating in Adolescents With Obesity (EL TREA)

Determine the effectiveness of how limiting the time you eat within an early or late eating window and fasting for remainder of the day will impact weight loss and body mass index (BMI).

Recruiting

Interested in participating?

Request Info

Key information

Age range

12 year–21 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Hospital Los Angeles

Los Angeles, California, 90027, United States

Location status: Recruiting

Location contact

Alaina Vidmar

CONTACT

[email protected]

530-383-1732

About this study

In adults, there is growing evidence that early TRE is more effective in improving metabolic outcomes than other forms of TRE, however it is unclear whether adolescents will be able to adhere to such recommendations. Hence, in the present study we propose a 24-week, 2-arm, parallel randomized pilot trial in 100 adolescents (age 13-18 years, all gender expressions, anticipate 65% Latino) with obesity, to test the preliminary efficacy of early vs. late TRE on glycemic profiles, weight loss, and body composition. We hypothesize that, among adolescents who can adhere to the meal timing recommendations, early TRE will result in greater improvement in metabolic endpoints than late TRE. We will test the hypothesis with 3 specific aims: Aim 1: Test the effect of early vs. late TRE on glycemic profiles and β-cell function. Aim 2: Test the effect of early vs. late TRE on obesity and body composition, and cardiometabolic risk factors. Aim 3: Test the effect of early vs. late TRE on exploratory outcomes including sleep, physical activity, and dietary intake to explore how meal timing may influence occurrence, timing, and distribution of sleep and movement as well as dietary intake and caloric distribution. This study is the first study evaluating the effectiveness of early vs. late TRE in adolescents with obesity at risk for diabetes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 12-21 years with obesity (BMI>95th percentile)
  • participant must be willing and able to adhere to the assessments, visit schedules, and eating/fasting periods
  • baseline eating window greater than 12 hours.

Exclusion criteria

  • diagnosis of Prader-Willi Syndrome, brain tumor, or diabetes serious intellectual disability
  • previous diagnosis or subthreshold symptoms of an eating disorder (anorexia nervosa, bulimia nervosa, binge-eating disorder)
  • parent/guardian-reported physical, mental of other inability to participate in the assessments
  • previous bariatric surgery
  • current participation in other interventional weight loss studies.

Treatment and study plan

Early Time Restricted Eating

Behavioral

Early Time Restricted Eating 7 AM to 3 PM

Late Time Restricted Eating

Behavioral

Late Time Restricted Eating 12 PM to 8 PM

Primary outcomes

  1. Mean change in weight in excess of the 95th percentile at week 24 compared to baseline

    Time frame: week 24

    Change in weight in excess of the 95th percentile

Secondary outcomes

  1. Mean change in total body fat mass as measured on DEXA scan at week 24 compared to baseline

    Time frame: week 24

    Change in total body fat mass measured on DEXA scan

  2. Mean change in percent time in range as captured on contiguous glucose monitor at week 24 compared to baseline

    Time frame: week 24

    %TIR captured on CGM

  3. Mean change in hemoglobin A1c at week 24 compared to baseline

    Time frame: week 24

    HgA1c measured at baseline and week 24

  4. Mean change in ALT at week 24 compared to baseline

    Time frame: week 24

    ALT measured at baseline and week 24

  5. Mean change in systolic and diastolic blood pressure at week 24 compared to baseline

    Time frame: week 24

    Measured systolic and diastolic blood pressure at baseline and week 24

Study contacts

Contact information is provided by the study sponsor or research team.

Alaina Vidmar, MD

CONTACT

[email protected]

323-361-4606

Harvey Peralta

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Children's Hospital Los Angeles

Other

Registry information

Important dates

Study start
2023
Primary completion
2026
Study completion
2027
First posted
Feb 22, 2023
Registry last updated
Oct 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.